Biogen, up for an aducanuamb decision in days, could be ripe for activist incursion if it's handed a

[anonymous]

Biogen, up for an aducanuamb decision in days, could be ripe for activist incursion if it's handed a rejection: report

 

[anonymous]

Biogen probably should be spending more cash on late stage assets that align with the new portfolio strategy. Here’s the thing though, if these assets don’t work out, Biogen becomes an even juicier target for activists who want to force a merger.